Association of maternal CNVs in GSTT1/GSTT2 with smoking, preterm delivery, and low birth weight by Xiaojing Zheng et al.
ORIGINAL RESEARCH ARTICLE
published: 28 October 2013
doi: 10.3389/fgene.2013.00196
Association of maternal CNVs in GSTT1/GSTT2 with
smoking, preterm delivery, and low birth weight
Xiaojing Zheng1,2, Eleanor Feingold2,3, Kelli K. Ryckman4, John R. Shaffer3, Heather A. Boyd5,
Bjarke Feenstra5, Mads Melbye5, Mary L. Marazita6, Jeffrey C. Murray4 and Karen T. Cuenco3,6*
1 Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
2 Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
3 Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
4 Department of Pediatrics, College of Medicine, University of Iowa, Iowa City, IA, USA
5 Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
6 Department of Oral Biology, Center for Craniofacial and Dental Genetics, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Edited by:
Rui Feng, University of
Pennsylvania, USA
Reviewed by:
Timothy Thornton, University of
Washington, USA
Nathan Wineinger, Scripps
Translational Science Institute, USA
*Correspondence:
Karen T. Cuenco, University of
Pittsburgh, 100 Technology Drive,
Suite 500, Pittsburgh, PA 15219,
USA
e-mail: ktc14@pitt.edu
Preterm delivery (PTD) is an adverse birth outcome associated with increased infant
mortality and negative lifelong health consequences. PTD may be the result of interactions
between genetics and maternal/fetal environmental factors including smoking exposure
(SMK). A common deletion in the GSTT1 gene was previously reported to affect
birth outcomes in smokers. In this study, we dissect the associations among SMK, birth
outcomes, and copy number variations (CNVs) in the GSTT1/GSTT2 region. A preterm birth
case-control dataset of 1937 mothers was part of the GENEVA preterm birth study, which
included genome-wide genotyping used to identify CNVs. We examined the association
of SMK with birth outcomes, detected CNVs within the GSTT1/GSTT2 region using
PennCNV, and examined associations of the identified CNVs with preterm birth and with
birth weight (BW) in full term birth controls, including interactions with SMK. Finally, we
tested the association of CNVs in GSTT1/GSTT2 with SMK. We confirmed the association
of smoking with low BW and PTD. We identified 2 CNVs in GSTT2 (GSTT2a and GSTT2b),
1 CNV in GSTTP1 and 2 CNVs in GSTT1 (GSTT1a and GSTT1b). The GSTT2a deletion was
associated with reduced BW (−284 g, p = 2.50E-7) in smokers, and was more common in
smokers [odds ratio(OR) = 1.30, p = 0.04]. We found that the size of the reported common
deletion CNV in GSTT1 was larger than previously shown. The GSTTP1 and GSTT1b
null genotypes were in high linkage disequilibrium (LD) (D′ = 0.89) and less common
in smokers (OR = 0.68, p = 0.019 and OR = 0.73, p = 0.055, respectively). These two
deletions were in partial LD with GSTT2a and GSTT2b duplications. All 5 CNVs seem to
be associated with increased risk of preterm birth before 35 completed weeks. CNVs in
the GSTTT1/GSTT2 region appear associated with low BW and PTD outcomes, but LD
complicated these CNVs in GSTT1/GSTT2. In genetic association studies of BW, multiple
CNVs in this region need to be investigated instead of a single polymorphism.
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INTRODUCTION
Low birth weight (LBW) refers to the weight of a newborn being
less than 2500 g (Kramer, 1987) and occurs in 16% of all live-
births worldwide (deOnis et al., 1998). Birth weight is regulated
by two major processes: duration of gestation and intrauterine
growth rate. Preterm delivery (PTD) of babies born with less than
37 weeks of gestation is responsible for one-third to two-thirds of
infants with LBW (Arifeen et al., 2000; Martin et al., 2007). PTD
and LBW are independent risk factors for fetal and infant mortal-
ity. However, the causes of PTD and LBW are not clear. Multiple
factors may contribute to the development of LBW and/or PTD,
including genetic and environmental factors, and other spe-
cific maternal-fetal characteristics (e.g., demographic, obstetric,
nutritional factors, and maternal morbidity during pregnancy)
(Kramer, 1987). Based on twin studies, the heritabilites of low
birthweight (<2500 g) and PTD (<37 gestational weeks) are
estimated to be 37–42 and 36%, respectively (Clausson et al.,
2000).
One of the important environmental factors in birth outcomes
is maternal tobacco smoking. Smoking exposure may reduce
mean birth weight, and increase the risk of PTD and intrauter-
ine growth restriction (Asmussen and Kjeldsen, 1975; Asmussen,
1977; Nilsen et al., 1984; Ronco et al., 2005; Goldenberg and
Culhane, 2007; Haram et al., 2007). Part of the effect of smok-
ing on birth outcomes may be due to the metabolism of the
tobacco compound PAH (polycyclic aromatic hydrocarbons)
(Perera et al., 2005; Tsui et al., 2008; Wu et al., 2010). PAH
is a carcinogenic compound that is detoxified in a two-stage
process. PAHs are converted into procarcinogen, which is then
conjugated into excretal metabolites. The conjugation is catalyzed
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by the product of the gene GSTT1 (Glutathione S-transferase
theta 1), which belongs to the theta class of GSTs. The class
members, GSTT1 and GSTT2, are located on human chromo-
some 22. The genes are approximately 50 kb away from each
other, with a GSTT pseudo gene (GSTTP1) located between them.
GSTT1 and GSTT2 share 55% amino acid sequence identity and
have detoxification roles (Coggan et al., 1998), which make the
GSTT1/GSTT2 region an interesting candidate for explaining
smoking-induced adverse effects.
A small deletion in GSTT1 is the only reported common copy
number variant (CNV) in the region. A null genotype (homozy-
gous deletion) of GSTT1 modifies the effect of maternal smok-
ing on birth outcomes. Smokers have infants with lower mean
birth weight compared to non-smokers; however, the reduction
varies according to the GSTT1 copy number. Mean birth weight
decreases dramatically in smokers with the GSTT1 null genotype
compared to smokers with the GSTT1 wild-type genotype (Wang
et al., 2002; Wu et al., 2007; Grazuleviciene et al., 2009; Aagaard-
Tillery et al., 2010). It is unclear whether other CNVs may exist in
the GSTT1/GSTT2 region.
The goal of this study was to explore whether additional CNVs
are distributed in GSTT1/GSTT2 and to investigate their associa-
tions with smoking and birth outcomes. First, we detected CNVs
in the GSTT1/GSTT2 regions. Next, we examined the associa-
tion of GSTT1/GSTT2 CNVs with birth outcomes, stratifying
by smoking status. Finally we investigated the relationship of
GSTT1/GSTT2 CNVs with smoking.
MATERIALS AND METHODS
STUDY POPULATIONS
Data were generated as part of the GENEVA (Gene Environment
Association studies) preterm birth study (http://www.ncbi.nlm.n
ih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000103.v1.p1).
This study is part of dbGAP (http://www.ncbi.nlm.nih.gov/gap)
(Mailman et al., 2007). A case-control study of preterm birth
identified ∼1000 mother-child case pairs (spontaneous births
at <37 weeks of gestation), and 1000 mother-child controls
pairs (spontaneous births at 40 weeks of gestation) from the
Danish National Birth Cohort (DNBC) (Olsen et al., 2001). 1937
mothers had genotype information generated from the Illumina
Human660W-Quad chip. Of these, 893 had a preterm birth,
978 delivered at term, and 66 were categorized as neither case
nor control (births between 37 and 39 weeks of gestation) and
were excluded from the current study. Smoking data came from
DNBC prenatal interviews conducted at several points during
gestation. For the purposes of this study, we categorized smoking
as “any smoking” or “no smoking” during pregnancy.
GENOTYPING AND QUALITY CONTROL
Complete genotyping and data cleaning reports for the GENEVA
preterm birth study are available in dbGAP (https://www.
genevastudy.org/sites/www/content/files/datacleaning/data_clean
ing_reports/Preterm_Birth_DN_Murray_DCR_9-3-2010.pdf).
The genotyping quality was extremely high. For this CNV study,
SNPs were not filtered by minor allele frequency or Hardy-
Weinberg equilibrium testing, as those filters tend to remove
precisely the SNPs in CNV regions.
CNV CALLS BY PennCNV AND IDENTIFICATION OF CNV REGIONS
CNV calls for mothers were generated using the PennCNV soft-
ware and published guidelines (2009Aug27 version) (Wang et al.,
2007). A GC wave adjustment option was applied in PennCNV.
We removed all samples that had been genome-wide amplified,
as CNV calling in such samples is generally poor (Zheng et al.,
2012). Samples were then filtered using the criterion log R ratio
standard deviation (LRRSD) >0.3 resulting in 1617 out of 1937
mothers eligible for further analysis. All analyses were restricted
to autosomes. Human genome build 36 was used for this study.
CNVs with copy number >2 were defined as duplications, while
those with copy number <2 were considered deletions. Each
CNV contained at least three consecutive markers. For CNVs with
high allele frequency of a deletion, we also applied the PennCNV
validation algorithm.
To identify CNV regions between GSTT1 to GSTT2, we first
merged CNVs detected by PennCNV if the length of overlap
between any two CNVs is greater than 50% of the size of at least
one of the CNVs. The start position of the resulting CNV region
is defined as the minimum base pair position of the overlapping
CNVs, and the end position is defined to be the maximum base
pair position of the overlapping CNVs.
STATISTICAL ANALYSIS
We examined the association of smoking with PTD and birth
weight in our dataset using logistic and linear regression, respec-
tively. The association of CNVs with birth weight was evaluated
using linear regression. Since preterm birth is known to be
collinear with birth weight, analyses of birth weight were per-
formed in the controls (full term births) only. The relationship
between CNVs and PTD stratified by smoking status was exam-
ined using logistic regression. The association between CNVs
and smoking adjusted for preterm birth state was assessed using
logistic regression.
In regression analysis, deletion CNVs [copy number
(CN) < 2] and duplication CNVs (CN > 2) were coded as
dummy variables and compared to normal copy number
(CN = 2), for two separate comparisons. For common deletions
(allele frequency of deletion >35%) in GSTT1 and GSTTP1, we
compared the homozygous deletions CN = 0 vs. CN > 0 as a
single dichotomous comparison. We adjusted for infant sex and
maternal BMI in all regression models. All calculations were
completed in R (version 2.15.1) (R Development Core Team,
2009). Associations with p = 0.05 were considered of interest
and are reported without additional correction. The linkage
disequilibrium (LD) of two CNVs was measured by D′.
RESULTS
ASSOCIATION BETWEEN SMOKING AND BIRTH OUTCOMES
The characteristics of the DNBC/GENEVA mothers by case and
control status are described in Table 1. The average maternal
BMI was similar between cases and controls (p = 0.70). As
expected, the average birth weight in infants of cases was 2463 g,
which is significantly lower than in controls 3719 g (p < 2.20E-
16). The prevalence of smoking reported during pregnancy was
significantly higher in cases than in controls (31.4 and 26.2%
respectively, p = 0.029).
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Table 1 | The characteristics of the DNBC/GENEVA mothers
(case/control) plus infant birthoutcomes.
Maternal characteristics Cases Controls P-value
(gestational (gestational
(weeks < 37) (weeks = 40)
N =736 N =881
Birth weight, mean (SD), g 2463 (650) 3719 (459) <2.20E-16
gestational age, mean (SD), wk 33.9 (2.2) 40.0 (0)
SMOKING DURING PREGNANCY, %
No 68.6 73.8 0.029
Yes 31.4 26.2
maternal BMI, mean (SD) 23.4 (4.5) 23.5 (4.0) 0.70
INFANT SEX, %
Male 53.2 53.2 0.98
Female 46.8 46.8
N, number of mothers; SD, standard deviation; BMI, body mass index; g, grams;
wk, weeks.
We conducted association analysis of birth weight in controls
(40 weeks gestation) only. Smoking was a significant predictor
of birth weight (p = 2.01E-10). Among the infants with moth-
ers who smoked, the mean birth weight was 277.87 g lower than
in the non-smoking group.
IDENTIFICATION OF CNVs
Using the methods described above, we found five potential CNV
regions located in three genes in the area of GSTT1∼GSTT2
(Figure 1). Two CNVs were in GSTT2 (GSTT2a and GSTT2b),
one was in GSTTP1, and the remaining two CNVs were in
GSTT1 (GSTT1a and GSTT1b). These five CNVs were not inde-
pendent. The duplications in GSTT2 (GSTT2a and GSTT2b)
are correlated with two deletions, located in GSTTP1 and
GSTT1 (GSTT1b). Detailed information on the relationship
among these CNVs is summarized in the Table A1. None of
our array markers were located within the GSTT1 null geno-
type region that has previously been reported in the litera-
ture, but our GSTT1b region spans that location (see Figure 1),
which suggests that the deletion region is larger than previously
reported.
ASSOCIATION BETWEEN CNVs IN GSTT1/GSTT2 AND BIRTH WEIGHT
The 5 CNVs were assessed for association with birth weight in
controls (full term births) (Tables 2, 3A,B). The GSTT2b dele-
tion was the only CNV associated with birth weight in full
term controls (Table 3B, 122.0 g, p = 0.05). The GSTT2a dele-
tion was borderline associated birthweight regardless of smok-
ing status and when examined in solely smokers (Table 3B.
in all subjects, p = 0.060; in smokers only, p = 0.07). The
GSTT2b deletion was also borderline associated with birth-
weight when looking in non-smokers only (Table 2; p = 0.09
among full-term births only). None of the interactions between
these five CNVs with smoking were near statistical significance
after evaluating a model of birthweight regressed on mater-
nal BMI, infant sex, genotype, and genotype x smoking status
(Table 2, Pint).
FIGURE 1 | CNV calls in a sample of 34 subjects. Each dot represents a
marker. Each line represents a CNV called by PennCNV. Red is duplication,
blue is deletion. No marker was located in the region of the
previously-reported GSTT1 null genotype.
ASSOCIATION BETWEEN CNVs IN GSTT1/GSTT2 AND PRETERM BIRTH
We then analyzed the association of CNVs with preterm birth
(gestational weeks <37) and with birth <35 gestational weeks
(Table 2). None of the CNVs were significantly associated with
the risk of preterm birth among smoking and non-smoking
mothers considered separately (Table 4). However, the GSTT2a
duplication was borderline significantly associated with an
increased risk of birth <35 weeks (odds ratio = 1.44, p =
0.08) in non-smokers (Table 2). Among smokers, the dupli-
cation did not significantly influence the risk of birth <35
weeks (Table 4; odds ratio = 1.06, p = 0.88). The GSTT2a
deletion was associated with reduced birth weight in full
term controls with borderline significance when smoking sta-
tus was not considered (Table 3B; −65.3 g, p = 0.06), but was
not associated with preterm birth or birth before 35 weeks
(Table 2). Three CNVs [GSTT2b duplication (odds ratio =
1.48, p = 0.05), GSTTP1 deletion (odds ratio = 1.38, p =
0.09) and GSTT1b deletion (odds ratio = 1.42, p = 0.06)]
were all independently associated or borderline associated with
birth <35 weeks in non-smokers (Table 2). These three CNVs
were also in partial LD with each other. The deletions in
GSTTP1 and GSTT1b are common and the homozygous dele-
tion (null genotypes) frequencies are 15.5 and 15.8% respec-
tively. The duplication of GSTT2b when combined with the
effect of smoking was similar to the CNV’s effect among non-
smokers (Table 2: odds ratio = 1.86, p = 0.05). The deletion of
GSTT1b was associated with increased risk of birth before
35 weeks (odds ratio = 1.42, p = 0.06) in non-smokers and
when combined with smoking had comparable effect but was
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Table 2 | Association of CNVs in GSTT1/GSTT2 with birth weight and preterm birth.
Outcome Full term birth only (controls)1 All subjects (cases + controls)2
Birth weight (g) Preterm Birth Very Preterm3 Birth
(gestational weeks <37) (gestational weeks <35)
GENE × SMOKING STATUS COMBINATION
Genotype Smk N1 β (SE ) P -value Pint# N2 Freq (%) Odds ratio P**-value Freq (%) Odds ratio P-value
GSTT2a
Normal − 375 Ref 643 41.7 Ref 18.8 Ref
+ 124 −162 (47) 5.90E-04 242 48.8 1.32 0.07 26.8 1.57 0.01
Duplication − 89 20 (53) 0.70 0.87 162 45.1 1.15 0.45 24.7 1.44 0.08
+ 23 −124 (95) 0.19 50 54.0 1.55 0.13 28.0 1.68 0.12
Deletion − 186 −20 (41) 0.62 0.18 311 40.2 0.91 0.49 19.3 1.04 0.81
+ 84 −284 (55) 2.50E-07 152 44.7 1.14 0.48 20.4 1.02 0.93
GSTT2b
Normal _ 512 Ref 882 41.9 Ref 19.3 Ref
+ 193 −199 (38) 2.55E-07 362 46.7 1.21 0.15 24.3 1.29 0.09
Duplication − 91 25 (51) 0.62 0.45 163 44.2 1.09 0.61 25.8 1.48 0.05
+ 23 −90 (94) 0.33 51 54.9 1.67 0.08 31.4 1.86 0.05
Deletion − 45 117 (69) 0.09 0.68 69 34.8 0.63 0.09 13.0 0.58 0.16
+ 14 −141 (119) 0.24 29 51.7 1.47 0.31 17.2 0.85 0.74
GSTTP1
Present − 544 Ref 928 41.4 Ref 18.8 Ref
+ 204 −204 (37) 6.11E-08 390 47.7 1.31 0.03 24.6 1.35 0.04
Null − 106 47 (47) 0.32 0.62 188 43.6 1.11 0.53 24.6 1.38 0.09
+ 27 −105 (88) 0.23 54 50.0 1.31 0.35 25.9 1.48 0.24
GSTT1a
Normal − 570 Ref 974 41.5 Ref 20.2 Ref
+ 199 −213 (37) 1.27E-08 388 48.7 1.34 0.02 25.5 1.29 0.07
Duplication − 26 −102 (89) 0.25 0.11 51 49.0 1.23 0.46 15.7 0.62 0.26
+ 13 −62 (129) 0.63 22 40.9 1.05 0.90 18.2 0.89 0.83
Deletion − 54 61 (65) 0.34 0.87 91 40.7 0.97 0.88 17.6 0.87 0.62
+ 19 −131 (109) 0.23 34 44.1 1.07 0.85 20.6 0.95 0.92
GSTT1b
Present − 543 Ref 927 41.4 Ref 18.7 Ref
+ 202 −200 (37) 1.12E-07 386 47.7 1.31 0.03 24.6 1.35 0.04
Null − 107 57 (47) 0.23 0.83 189 43.4 1.09 0.58 24.9 1.42 0.06
+ 29 −121 (85) 0.15 58 50.0 1.32 0.33 25.9 1.48 0.22
Marginal effects of CNVs and joint effects of CNV with smoking status reported.
1Mothers with full term births. These subjects are known as “controls” and used for the All subjects study sample.
2Cases (preterm or very preterm birth mothers) and “controls”3. Research definition of preterm birth.
3Ref is the subgroup designated as the referent group for comparison with various CNV subgroups.
a and b were used to distinguish different CNVs in the same gene.
Smk is mother reported no smoking (−) or smoking (+) during pregnancy.
N1 is the number of mothers with full-term birth only.
N2 is the total number of mothers (cases + controls).
Freq (%) is the percentage of N2 with infant births of either <37 or <35 gestational weeks.
β (SE) is the regression coefficient and standard error estimate for the model under evaluation.
P-value is from the model of Outcome = α + maternal BMI + infant sex + (CNV + SMK). Each combination of genotype and smoking status was compared to
subjects with normal CNV genotype and who were non-smokers.
Pint is the p-value for the interaction term in the model is Outcome = α + maternal BMI + infant sex + SMK + CNV + CNV × SMK.
not statistically significant as joint risk factors (Table 2. odds
ratio = 1.48, p = 0.22). The marginal effect in smokers was
not significant either (Table 4B: odds ratio = 1.09, p = 0.80).
The odds ratio for the effect of the GSTTP1 deletion on
birth before 35 weeks was similar [Table 2: odds ratio = 1.38
(p = 0.09) and 1.48 (p = 0.24), respectively, in non-smokers and
when considered jointly with smoking] to that of the GSTT1b
deletion.
ASSOCIATION BETWEEN GSTT1/GSTT2 AND SMOKING
To better understand the relationship among birth outcomes,
smoking, and the CNVs we examined, we also tested association
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Table 3 | Effect of CNVs inGSTT1/GSTT2 region on birth weight in full term birth mothers∧.
(A) Duplication
All1 Smokers Non-smokers
Gene Start End No. of Change of P-value4 Change of P-value Change of P-value
symbol position position SNPs2 mean BW3 mean BW mean BW
GSTT2a 22613516 22623656 11 25.1 0.60 38.09 0.71 12.2 0.82
GSTT2b 22653131 22671429 30 45.5 0.32 98.31 0.33 13.9 0.78
GSTTP1 22679906 22685981 10 − − − −
GSTT1a 22693154 22694601 17 −51.5 0.50 122.58 0.35 −113.8 0.20
GSTT1b 22695592 22723364 23 − − − −
(B) Deletion
All Smokers Non-smokers
Gene Start End No. of Change of P-value Change of P-value Change of P-value
symbol position position SNPs mean BW mean BW mean BW
GSTT2a 22613516 22623656 11 −65.3 0.06 −116.8 0.07 −24.9 0.54
GSTT2b 22653131 22671429 30 122.0 0.05 91.1 0.47 120.2 0.08
GSTTP1 22679906 22685981 10 66.7 0.12 92.1 0.33 41.1 0.39
GSTT1a 22693154 22694601 17 80.3 0.15 33.4 0.76 97.4 0.13
GSTT1b 22695592 22723364 23 68.6 0.11 79.8 0.38 49.7 0.29
Duplication (A) and deletion (B) effects.
∧“Full term birth mothers” are designated “controls” elsewhere.
1“All” consists of Smoker and Non-smoker mothers combined.
2“No. of SNPs” is the number of SNPs typed within the region defined by start and end positions.
3“Change of mean BW” is the amount of birthweight (in grams) altered that is attributed to the CNV. This value is obtained from a regression coefficient estimate
for the CNV in the model while adjusting for maternal body mass index and infant sex.
“P-value” is the p-value associated with change of mean BW.
−No estimate obtained.
between the CNVs and smoking. Our examination of the
relationship between smoking and GSTT1/GSTT2 CNVs while
adjusting for birth weight indicated that the duplication CNVs
were not significantly associated with smoking. However, the
deletion CNV in GSTT2a was significantly associated with smok-
ing (Table 5. odds ratio of smoking vs. non-smoking in carriers
of this deletion = 1.30, p = 0.04). This same deletion and smok-
ing were jointly associated with decreased birth weight (Table 2;
−284 g, p = 2.50 × 10E-07), but the deletion alone accounted for
less than half of the decreased weight (Table 3B. −116.8 g, p =
0.07) in smokers. Smokers were also less likely to have the dele-
tions in GSTTP1 and GSTT1b (Table 5: odds ratios = 0.68 (p =
0.02) and 0.73 (p = 0.06), respectively). These deletions tend
to increase birth weight in controls, although not significantly
(Table 2).
DISCUSSION
Linkage and SNP association studies have identified some
genetic factors that are associated with adverse birth out-
comes, including GSTT1. However, few CNV studies have been
conducted for LBW and PTD outcomes. We focused on exam-
ining CNVs in the region from GSTT1 to GSTT2 and inves-
tigating their association with adverse birth outcomes and
smoking.
Our finding that smoking may be associated both preterm
birth and birth weight is consistent with other reports (Horta
et al., 1997; Chan et al., 2001).
After identifying five CNV regions in GSTT2, GSTTP1, and
GSTT1, we noted the complex association patterns with preterm
birth and birth weight, which may be related to LD among the
CNVs. The GSTT2 duplications GSTT2a and GSTT2b), GSTTP1
deletion and GSTT1b deletion are in partial LD (see Table A1).
The GSTT2a deletion decreased the mean birth weight in infants
of smoking mothers and is more likely to be present in smok-
ers, but the weight change was of borderline statistical signifi-
cance. In contrast, theGSTT2b deletion increases the birth weight
(Table 3B: 120.2 g, p = 0.08) in infants of non-smoking moth-
ers and is more common in non-smokers (Table 5: odds ratio of
smoking vs. non-smoking= 0.68, p = 0.20), but again the weight
change was of borderline statistical significance. Interestingly, nei-
ther of the GSTT2 deletions was associated with preterm birth
or “very preterm” birth (<35 weeks) (Windham et al., 2000;
Danileviciute et al., 2012), but bothGSTT2 duplications appear to
be associated with increased risk of birth before 35 weeks in non-
smokers, and associated with an even higher risk when smoking
and the duplications were considered jointly. These findings sug-
gest that GSTT2 may have a role in detoxification of tobacco,
although it is also possible that these results are explained by LD
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Table 5 | Association of CNVs in the region from GSTT1/GSTT2
region with smoking∧.
Duplication Deletion
Gene Start End Odds P-value Odds P-value
symbol position position ratio ratio
GSTT2a 22613516 22623656 0.82 0.27 1.30 0.04
GSTT2b 22653131 22671429 0.77 0.12 0.68 0.20
GSTTP1 22679906 22685981 − − 0.68 0.02
GSTT1a 22693154 22694601 1.08 0.76 0.94 0.76
GSTT1b 22695592 22723364 − − 0.73 0.06
∧Comparison of CNV with smoking status adjusting for birth weight.
−No estimate obtained.
with other polymorphisms or multiple testing effects. CNVs in
GSTT2may influence the metabolism of nicotine, and exacerbate
the toxic effects of smoking.
The deletions in GSTTP1 were in high LD with GSTT1b
(22,695,592–22,725,333 bp) (D′ = 0.89) and in moderate LD
with two duplications in GSTT2 (D′ = 0.62). We did not observe
significant effects of GSTTP1 and GSTT1b deletions on birth
weight in full term controls, but they were associated with
increased risk of birth before 35 weeks in both non-smokers and
smokers, with the odds ratio slightly higher when the deletions
were considered jointly with smokers. This suggests that GSTTP1
and GSTT1b deletions are associated with reduced birth weight
through very preterm birth, but the effect on birth weight was
not detected when including full term infants. We also found that
GSTTP1 and GSTT1b deletions were less likely to occur in smok-
ers. Smoking could be a proxy for some other linked yet unknown
behavior or may be independently associated with these deletion
CNVs.
We compared our CNV results in GSTT1 and GSTT2 with
published findings for the previously described GSTT1 CNV,
which was reported to modify the effect of smoking on birth
weight (Wang et al., 2002; Wu et al., 2007; Grazuleviciene et al.,
2009; Aagaard-Tillery et al., 2010). Smokers with the null geno-
type of GSTT1 had infants with lower mean birth weight than
those with the wildtype genotype of GSTT1. The deletion’s physi-
cal genomic position (22,698,742–22,706,887 bp on chromosome
22) was not covered by the HumanHap660 chip resulting in a
marker gap between 22,697,104, and 22,713,954 bp in our arrays.
However, our GSTT1b deletion encompasses the reported GSTT1
null genotype region. It is notable that the frequency of the
homozygous GSTT1b deletion CNV in our data was highly con-
sistent with the previously reported frequency of the GSTT1 null
genotype in Denmark (15%) (Saadat et al., 2001). In contrast to
most previous studies, we were able to examine the influence of
GSTT1a and GSTT1b deletions on fetal growth in women with
full term births, which means that we were able to examine the
effects on birth weight more or less independently of effects on
gestational age. We did not find significant association of GSTT1
deletions with birth weight in full term birth, nor did we observe
interactions of genotypes and smoking status on birth weight
in controls. This may be due to the relatively small number of
mothers who smoked during pregnancy, or due to the smoking
measurement being a dichotomous measure. When contrasted
with earlier reports of a GSTT1—smoking interaction impacting
birth outcomes, the current study’s lack of evidence for an inter-
actionmay be attributed to differences in confounders included in
models, variability of smoker definitions, and this study’s mothers
being categorized as non-smokers based on the pregnancy time
period only.
A single SNP (rs1622002) in GSTT2 has been associated with
metabolism ofmajor tobacco carcinogen PAH (Wang et al., 2008),
but this SNP was not included in the present study’s genotype
panel.
There are several epidemiologic limitations in our study.
Smoking was recorded as any smoking present during pregnancy,
which did not consider the influence of smoking in different
trimesters. Secondly, regressions were adjusted for some demo-
graphic factors, but excluded adjustments for psychosocial fac-
tors. Statistical evaluations were not corrected for multiple testing
which tempers the conclusions that can be drawn about associa-
tions, but the uncorrected p-values do suggest a prioritization of
findings to pursue in future studies.
In addition to the epidemiological issues, CNV calls are noto-
riously error-prone. It is not feasible to validate specific CNV calls
within the context of a large-scale association study. However, for
any given CNVwith calling error rates independent of phenotype,
those errors should only reduce power and not cause bias in the
association measure (Zheng et al., 2012). We have no reason to
expect CNV calling biases in the current study, so we feel that our
results are quite robust. Moreover, the fact that our frequency for
the GSTT1b homozygous deletion was an almost perfect match
to the frequency reported in this population for the known dele-
tion was very reassuring.We did not compare our PennCNVCNV
calls to any other algorithm in this study, although we did so pre-
viously in a more explicit algorithm comparison (Zheng et al.,
2012).
Despite these limitations, our study is able to shed light on
CNVs in smoking-associated adverse birth outcomes. Our can-
didate gene analysis in GSTT1/GSTT2 and identification of five
CNVs that appear to be associated with birth weight and/or birth
before 35 weeks is novel. The distribution and LD pattern of
these CNVs are more complicated than expected, which may
impact our understanding of the relationship between the GSTT1
deletion and adverse birth outcomes. Follow-up genetic associ-
ation studies of birth weight need to include multiple CNVs in
this region instead of single polymorphisms. Additional stud-
ies including molecular evidence will be needed to validate the
detected CNVs and replicate these results.
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APPENDIX
Table A1 | Cross-tabulation and linkage disequilibrium of CNVs in
GSTT1/GSTT2 region. Duplication (Dup) or deletion (Del) is present
(+) or absent (−).
Dup GSTT2b Del GSTT2b
+ − + −
Dup GSTT2a + 188 20 Del GSTT2a + 75 388
− 26 1326 − 23 1074
D′ = 0.87 D′ = 0.67
Del GSTT2b Dup GSTT2b
+ − + −
Dup GSTT2a + 0 208 Del GSTT2a + 0 463
− 98 1254 − 214 883
D′ = 0.15 D′ = 0.43
Del GSTTP1 Del GSTTP1   
+ − + −
Del GSTT2b + 0 98 Dup GSTT2b + 144 70
−
228
222
57 1275
6
1234
−
84 1262
D′ = 0.17 D′ = 0.62
Del GSTT1b 
+ −
Del GSTTP1  +
−
D′ = 0.89
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